Unknown

Dataset Information

Adoptive Treg Cell Therapy in a Patient With Systemic Lupus Erythematosus.


ABSTRACT:

Objective

Adoptive Treg cell therapy has great potential to treat autoimmune disease. Currently, very little is known about how these cells impact inflamed tissues. This study was undertaken to elucidate how autologous Treg cell therapy influences tissue inflammation in human autoimmune disease.

Methods

We describe a systemic lupus erythematosus (SLE) patient with active skin disease who received adoptive Treg therapy. We comprehensively quantified Treg cells and immune activation in peripheral blood and skin, with data obtained at multiple time points posttreatment.

Results

Deuterium tracking of infused Treg cells revealed the transient presence of cells in peripheral blood, accompanied by increased percentages of highly activated Treg cells in diseased skin. Flow cy

SUBMITTER: Dall'Era M 

PROVIDER: S-EPMC6447289 | biostudies-literature | 2019 Mar

REPOSITORIES: biostudies-literature